Principal Investigator
Scott Elman
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20250246
Clinical Trial Summary
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults with Moderate to Severe Hidradenitis Suppurative - The CEDAR Study
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other